ImportRefusal LogoImportRefusal

Suzhou MyLand Pharm&Nutrition Inc.

⚠️ Moderate Risk

FEI: 3010625389 • Suzhou, Jiangsu • CHINA

FEI

FEI Number

3010625389

📍

Location

Suzhou, Jiangsu

🇨🇳

Country

CHINA
🏢

Address

China (Jiangsu) Pilot Free Trade Zone Second Floor, China (Jiangsu) Pilot Free Trade Zone; Bachengzhen Kunshan, Suzhou, Jiangsu, China

Moderate Risk

FDA Import Risk Assessment

38.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

17
Total Refusals
17
Unique Violations
6/16/2020
Latest Refusal
6/26/2014
Earliest Refusal

Score Breakdown

Violation Severity
54.1×40%
Refusal Volume
46.5×30%
Recency
0.0×20%
Frequency
28.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

167×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3203×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

2183×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

2562×

INCONSPICU

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

23002×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

21202×

UNSFDIETSP

The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

821×

RX LEGEND

The article appears to be a prescription drug without a prescription drug legend as required by Section 503(b)(4).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

2381×

UNSAFE ADD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.

2601×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

Refusal History

DateProductViolationsDivision
6/16/2020
54CIR09GLYCINE (PROTEIN)
118NOT LISTED
2280DIRSEXMPT
Division of West Coast Imports (DWCI)
9/4/2018
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
238UNSAFE ADD
260FALSE
Division of West Coast Imports (DWCI)
9/7/2017
66BIS99STIMULANT N.E.C.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
Division of Southeast Imports (DSEI)
7/13/2017
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
Division of West Coast Imports (DWCI)
7/13/2017
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
Division of West Coast Imports (DWCI)
6/26/2017
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
Division of West Coast Imports (DWCI)
10/31/2016
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/3/2016
54FYY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
256INCONSPICU
Cincinnati District Office (CIN-DO)
3/1/2016
53PY99OTHER COSMETIC RAW MATERIALS, N.E.C.
475COSMETLBLG
Cincinnati District Office (CIN-DO)
3/1/2016
54YBY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
Cincinnati District Office (CIN-DO)
10/28/2015
54YBY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
Seattle District Office (SEA-DO)
9/29/2015
61NCS99ANTI-DEPRESSANT N.E.C.
118NOT LISTED
16DIRECTIONS
336INCONSPICU
Cincinnati District Office (CIN-DO)
6/2/2015
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
2120UNSFDIETSP
Cincinnati District Office (CIN-DO)
7/16/2014
54YCR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
320LACKS FIRM
New Orleans District Office (NOL-DO)
7/14/2014
54YBY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
218LIST INGRE
2300DIETARYLBL
256INCONSPICU
320LACKS FIRM
482NUTRIT LBL
New Orleans District Office (NOL-DO)
7/14/2014
66VCS99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
333LACKS FIRM
75UNAPPROVED
82RX LEGEND
New Orleans District Office (NOL-DO)
6/26/2014
54YBY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2120UNSFDIETSP
320LACKS FIRM
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Suzhou MyLand Pharm&Nutrition Inc.'s FDA import refusal history?

Suzhou MyLand Pharm&Nutrition Inc. (FEI: 3010625389) has 17 FDA import refusal record(s) in our database, spanning from 6/26/2014 to 6/16/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Suzhou MyLand Pharm&Nutrition Inc.'s FEI number is 3010625389.

What types of violations has Suzhou MyLand Pharm&Nutrition Inc. received?

Suzhou MyLand Pharm&Nutrition Inc. has been cited for 17 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Suzhou MyLand Pharm&Nutrition Inc. come from?

All FDA import refusal data for Suzhou MyLand Pharm&Nutrition Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.